- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Incannex erweitert klinischen Beirat für PSX-001-Programm um drei Experten | 1 | Investing.com Deutsch | ||
| Do | Incannex appoints three experts to clinical advisory board for PSX-001 | 1 | Investing.com | ||
| Do | Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board | 1 | GlobeNewswire (USA) | ||
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Do | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Incannex gründet klinischen Beirat für Therapie gegen Angststörungen | 2 | Investing.com Deutsch | ||
| 22.01. | Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program | 123 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies... ► Artikel lesen | |
| 22.01. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | Jahreshauptversammlung von Incannex Healthcare: Direktoren gewählt und Prüfer bestätigt | 1 | Investing.com Deutsch | ||
| 14.01. | Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026 | 228 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies... ► Artikel lesen | |
| 14.01. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.25 | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | Why Incannex Is Rising In Pre-market? | 1 | RTTNews | ||
| 03.12.25 | Incannex erhält Fast-Track-Status der FDA für Medikament gegen Schlafapnoe | 4 | Investing.com Deutsch | ||
| 03.12.25 | FDA grants fast track designation to Incannex's OSA treatment | 2 | Investing.com | ||
| 03.12.25 | Incannex Healthcare: Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) | 267 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies... ► Artikel lesen | |
| 03.12.25 | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.11.25 | Incannex Healthcare Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 30.10.25 | Incannex Healthcare Inc. - 8-K, Current Report | 14 | SEC Filings | ||
| 22.10.25 | Incannex granted extension by Nasdaq to regain compliance with minimum bid price requirement | 1 | Seeking Alpha |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,970 | -1,19 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler liefert wie geplant und erzielt 2025 erneut Rekordjahr | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vorläufiges Ergebnis
Eckert & Ziegler liefert wie geplant und erzielt 2025 erneut Rekordjahr
29.01.2026 / 12:20 CET/CEST
Für... ► Artikel lesen | |
| MCKESSON | 692,80 | -1,23 % | McKesson Corporation Completes Divestiture of Norwegian Operations | McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group.
McKesson... ► Artikel lesen | |
| SENSEONICS | 5,750 | -7,26 % | Senseonics Holdings, Inc.: Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor | GERMANTOWN, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,260 | +1,88 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results | Updated interim results from the Company's [212Pb]VMT-a-NET Phase 1/2a study supporting the therapy's compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025... ► Artikel lesen | |
| ITONIC | 0,477 | -2,73 % | iTonic Holdings Ltd - 6-K, Report of foreign issuer | ||
| SRX HEALTH SOLUTIONS | 0,134 | -4,43 % | SRx Health Solutions, Inc.: SRx Health Solutions Regains Compliance with NYSE | NORTH PALM BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that the New York Stock Exchange ("NYSE") has accepted the... ► Artikel lesen | |
| MOVANO | 17,400 | -7,00 % | Morning Market Movers: Movano, Direct Digital Holdings, Ryvyl, Erayak Power Solution See Big Swings | SANTA CLARA (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,170 | +0,29 % | HV-Termine: Hauptversammlungen bei CGRE, Healthineers, q.beyond, Schott, Siemens, Stabilus, ThyssenKrupp, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS | 47,210 | +1,16 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
26.01.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,910 | +1,28 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ENVUE MEDICAL | 3,230 | -15,67 % | ENvue Medical, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 28,960 | -0,55 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 23,870 | -1,04 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 22,540 | +0,18 % | Alignment Healthcare (ALHC) Drops 12% on Medicare Flat Funding | ||
| BRIGHTSPRING HEALTH SERVICES | 39,270 | -1,41 % | BrightSpring Health stock price target raised to $46 by TD Cowen |
Das Unternehmen INCANNEX HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,009 (-2,94 %) liegt der Kurs bei 0,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.